EDITORIAL | |
“International Centres of Excellence in Hospital Pharmacy”; a SEFH new initiative; the role of the clinical pharmacist in the hospital antibiotic stewardship in Northern Ireland
Elena Alba Álvaro-Alonso, Mamoon Aldeyab, Linden Ashfield, Fiona Gilmore y Montserrat Pérez-Encinas Farm Hosp. 2016;40(4):233-236 |
|
ORIGINALS | |
Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management area
María Rosa Cantudo Cuenca, María Isabel Guzmán Ramos, María Dolores Cantudo Cuenca, Mercedes Manzano García, María del Carmen Saborido Cansino y Ana Sánchez Pedrosa Farm Hosp. 2016;40(4):237-245 |
|
Analysis of the medication reconciliation process conducted at hospital admission
María Beatriz Contreras Rey, Yolanda Arco Prados y Ernesto Sánchez Gómez Farm Hosp. 2016;40(4):246-259 |
|
Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
Rocío Jiménez-Galán, María-Rosa Cantudo Cuenca, María Aguas Robustillo-Cortés, Y. Borrego Izquierdo, Carmen Victoria Almeida-Gonzalez y Ramón Morillo-Verdugo Farm Hosp. 2016;40(4):272-278 |
|
Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
Beatriz López Centeno, Roberto Collado Borrell, Montserrat Pérez Encinas, María Luisa Gutiérrez García y Patricia Sanmartin Fenollera Farm Hosp. 2016;40(4):279-286 |
|
Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES Study)
Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero, Herminia Navarro Aznárez, Sergio Fernández Espínola, Ismael Escobar Rodríguez y José Manuel Ventura Cerdá Farm Hosp. 2016;40(4):287-301 |
|
COMPLETE JOURNAL | |
ARTICLE OF OPINION | |
Reflection on the pharmaceutical service in nursing homes; understanding reality to cover needs
Juan F. Peris-Martí, Elia Fernández-Villalba, Patricia Bravo-José, Carmen Sáez-Lleó y María García-Mina Freire Farm Hosp. 2016;40(4):302-315 |
|
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report
María Espinosa Bosch, Rocío Asensi Díez, Sara García Agudo y Ana Clopés Estela Farm Hosp. 2016;40(4):316-327 |
|